Dishman Carbogen Amics (NSE:DCAL) Beneish M-Score: -2.53 (As of Jun. 26, 2026)


NSE:DCAL Dishman Carbogen Amics Ltd NSE:DCAL
71 GF Score
Price ₹170.02
GF Value ₹236.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dishman Carbogen Amics Beneish M-Score?

Dishman Carbogen Amics NSE:DCAL -2.41% 71 Beneish M-Score is -2.53 as of Jun. 26, 2026. GuruFocus rates NSE:DCAL with a GF Score™ of 71/100 and a GF Value™ of ₹236.74 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 831 Biotechnology companies, Dishman Carbogen Amics ranks better than 56.8% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.53 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Dishman Carbogen Amics's Beneish M-Score or its related term are showing as below:

NSE:DCAL' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.61   Max: -1.21
Current: -2.53

During the past 13 years, the highest Beneish M-Score of Dishman Carbogen Amics was -1.21. The lowest was -3.10. And the median was -2.61.


Dishman Carbogen Amics Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Dishman Carbogen Amics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dishman Carbogen Amics Beneish M-Score Chart

Dishman Carbogen Amics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.79 -2.65 -2.87 -2.40 -2.53

Dishman Carbogen Amics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 0.00 0.00 0.00 -2.53

NSE:DCAL vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Dishman Carbogen Amics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's Beneish M-Score falls into.


NSE:DCAL
71GF Score
Dishman Carbogen Amics Ltd NSE:DCAL
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dishman Carbogen Amics Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Dishman Carbogen Amics for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8864+0.528 * 0.947+0.404 * 1.0282+0.892 * 1.0813+0.115 * 0.9387
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.033045-0.327 * 1.0312
=-2.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹6,762 Mil.
Revenue was ₹29,319 Mil.
Gross Profit was ₹25,231 Mil.
Total Current Assets was ₹28,421 Mil.
Total Assets was ₹119,233 Mil.
Property, Plant and Equipment(Net PPE) was ₹34,432 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹3,387 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹23,171 Mil.
Long-Term Debt & Capital Lease Obligation was ₹17,582 Mil.
Net Income was ₹975 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹4,915 Mil.
Total Receivables was ₹7,055 Mil.
Revenue was ₹27,115 Mil.
Gross Profit was ₹22,099 Mil.
Total Current Assets was ₹22,004 Mil.
Total Assets was ₹99,992 Mil.
Property, Plant and Equipment(Net PPE) was ₹32,005 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹2,937 Mil.
Selling, General, & Admin. Expense(SGA) was ₹1,555 Mil.
Total Current Liabilities was ₹19,248 Mil.
Long-Term Debt & Capital Lease Obligation was ₹13,895 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6761.6 / 29319) / (7055 / 27115)
=0.230622 / 0.260188
=0.8864

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(22098.5 / 27115) / (25231.1 / 29319)
=0.814992 / 0.860572
=0.947

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (28421 + 34432.2) / 119233.1) / (1 - (22004.2 + 32004.6) / 99991.5)
=0.472854 / 0.459866
=1.0282

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=29319 / 27115
=1.0813

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2937.4 / (2937.4 + 32004.6)) / (3386.9 / (3386.9 + 34432.2))
=0.084065 / 0.089555
=0.9387

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 29319) / (1554.7 / 27115)
=0 / 0.057337
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((17581.5 + 23170.5) / 119233.1) / ((13895.1 + 19247.9) / 99991.5)
=0.341784 / 0.331458
=1.0312

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(974.5 - 0 - 4914.5) / 119233.1
=-0.033045

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Dishman Carbogen Amics has a M-score of -2.53 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.53 mean?
Dishman Carbogen Amics (NSE:DCAL) has a Beneish M-Score of -2.53 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dishman Carbogen Amics and its competitors. According to the industry distribution chart, Dishman Carbogen Amics ranks #359 out of 831 companies in the Biotechnology industry, placing it in the top 43.2%.
Is Dishman Carbogen Amics' Beneish M-Score too high?
Dishman Carbogen Amics' current Beneish M-Score is -2.53. Based on the distribution chart, Dishman Carbogen Amics ranks #359 out of 831 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Dishman Carbogen Amics has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dishman Carbogen Amics' Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dishman Carbogen Amics ranks #359 out of 831 companies for Beneish M-Score. This puts Dishman Carbogen Amics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dishman Carbogen Amics and its competitors. Dishman Carbogen Amics's current Beneish M-Score is -2.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dishman Carbogen Amics stock overvalued right now?
Based on GuruFocus' analysis, Dishman Carbogen Amics (NSE:DCAL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹236.74, compared to a current price of ₹170.02 — trading 28.2% below its estimated fair value. The current Beneish M-Score is -2.53. Dishman Carbogen Amics' overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Dishman Carbogen Amics (NSE:DCAL), the current Beneish M-Score is -2.53 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?

Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued. The current stock price of ₹170.02 is trading 28.2% below its estimated GF Value™ of ₹236.74. GuruFocus considers Dishman Carbogen Amics to be Modestly Undervalued.

Key valuation signals for NSE:DCAL:

  • Beneish M-Score: -2.53
  • GF Value™: ₹236.74 vs. price of ₹170.02 (28.2% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dishman Carbogen Amics Business Description

Other Exchanges 540701:India
Address Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
71GF Score

Get the complete analysis for NSE:DCAL

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹170.02
Price
₹236.74
GF Value